Beyond Air Sales Jump 158 Percent
Beyond Air ( NASDAQ:XAIR ) , a medical device company focused on nitric oxide therapies, released its Q1 fiscal 2026 results on August 18, 2025. The key highlight was a 157% rise in GAAP revenue compared to the prior-year quarter, reaching $1.8 million.
IGC Pharma, Inc. ( IGC ) Reports Q1 Loss, Misses Revenue Estimates
IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +33.33% and -0.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Countdown to Premier ( PINC ) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of Premier (PINC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Taysha Gene Therapies, Inc. ( TSHA ) Reports Q2 Loss, Beats Revenue Estimates
Taysha Gene Therapies (TSHA) delivered earnings and revenue surprises of -28.57% and +15.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sonida Senior Living ( SNDA ) Reports Q2 Loss, Beats Revenue Estimates
Sonida Senior Living (SNDA) delivered earnings and revenue surprises of +79.49% and +0.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Ascend Wellness Holdings, Inc. ( AAWH ) Reports Q2 Loss, Misses Revenue Estimates
Ascend Wellness Holdings, Inc. (AAWH) delivered earnings and revenue surprises of -71.43% and -0.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Ardent Health, Inc. ( ARDT ) Q2 Earnings and Revenues Surpass Estimates
Ardent Health, Inc. (ARDT) delivered earnings and revenue surprises of +73.33% and +7.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Price Over Earnings Overview: Premier - Premier ( NASDAQ:PINC )
Looking into the current session, Premier Inc. PINC shares are trading at $21.00, after a 0.33% decrease. Over the past month, the stock decreased by 4.81%, but over the past year, it actually spiked by 6.60%.
Typenex Medical Awarded Agreements for Patient Identification and Manual Microbiology with Premier, Inc.
CHICAGO, July 14, 2025 /PRNewswire/ -- Typenex® Medical has been awarded two new national group purchasing agreements with Premier, Inc., a leading healthcare improvement company. The contracts for Patient Identification and Manual Microbiology will take effect August 1, 2025 and September 1, ...
Premier, Inc. ( PINC ) Q3 Earnings and Revenues Beat Estimates
Premier (PINC) delivered earnings and revenue surprises of 41.94% and 9.42%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC ( ICLR ) Beats Q1 Earnings Estimates
Icon PLC (ICLR) delivered earnings and revenue surprises of 3.57% and 0.58%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Charles River Laboratories ( CRL ) to Report a Decline in Earnings: What to Look Out for
Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Premier, Inc. ( PINC ) Expected to Beat Earnings Estimates: Should You Buy?
Premier (PINC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vascular Closure Device Market Size Projected to Grow to USD 3.03 Billion by 2030, Fuelled by Cardiovascular Disease Prevalence and Minimally Invasive Trends - The Insight Partners
US & Canada, April 03, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Apr, 01, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Vascular Closure Device Market Size and Forecast ( 2020-2030 ) , Global and Regional Share, Trend, and Growth Opportunity Analysis ...
Premier Has Stable Business But Analyst Remains Neutral - Here's Why - Premier ( NASDAQ:PINC )
JP Morgan reiterates Neutral rating on Premier with $19 target, citing stable business but near-term growth challenges. Premier faces risks from hospital budget constraints, GPO competition, and lower utilization, though improved trends could boost growth. Feel unsure about the market's next ...
After Plunging -7.95% in 4 Weeks, Here's Why the Trend Might Reverse for Premier ( PINC )
The heavy selling pressure might have exhausted for Premier (PINC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Danaher Rewards Shareholders With 18.5% Dividend Increase
DHR's measures to consistently reward shareholders through dividends and share buybacks hold promise.
Premier ( PINC ) Upgraded to Strong Buy: Here's What You Should Know
Premier (PINC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Down -10.11% in 4 Weeks, Here's Why Premier ( PINC ) Looks Ripe for a Turnaround
Premier (PINC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday? - Archer-Daniels Midland ( NYSE:ADM )
U.S. stocks gain despite geopolitical tensions as China imposes new tariffs and trade restrictions on U.S. goods and companies. Palantir surges 22% on strong earnings; gold hits a record high, silver rises 2.2% and Bitcoin drops to $99,000.
Premier, Inc. ( PINC ) Lags Q2 Earnings and Revenue Estimates
Premier (PINC) delivered earnings and revenue surprises of -6.90% and 1.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Sonicu awarded Pharmacy Temperature Monitoring agreement with Premier, Inc.
INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ -- Sonicu has been awarded a national group purchasing agreement for Temperature Monitoring with Premier, Inc.
CHAMPS Group Purchasing Announces Channel Partnership With OMNIA Partners
CHAMPS Group Purchasing is expanding its presence in the public sector through a collaborative agreement with OMNIA Partners
KUBTEC Awarded Tumor Localization Equipment and Related Accessories Category Agreement with Premier, Inc.
CONTACT:Richard WheltonHead / Director of Marketing, [email protected] ( 203 ) 364-8544 ext. 127 STRATFORD, Conn., Jan. 22, 2025 /PRNewswire/ -- KUBTEC has been awarded a national group purchasing agreement for GammaPRO with Premier, Inc.
BrightSpring Health Services, Inc. ( BTSG ) Soars 12.6%: Is Further Upside Left in the Stock?
BrightSpring Health Services, Inc. (BTSG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Best Income Stocks to Buy for December 24th
ENGIY, NJR and PINC made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 24, 2024.
Best Value Stocks to Buy for December 24th
PBYI, DDS and PINC made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 24, 2024.
Best Income Stocks to Buy for December 19th
WTBA, PINC and FG made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 19, 2024.
New Strong Buy Stocks for December 19th
MNDY, WTBA, NJR, PINC and PLAB have been added to the Zacks Rank #1 (Strong Buy) List on December 19, 2024.
BRIJ Medical, Inc. Awarded Breakthrough Technology Agreement in the Non-Invasive Skin Closure Category with Premier, Inc.
MARIETTA, Ga., Dec. 17, 2024 /PRNewswire/ -- BRIJ Medical, Inc. has been awarded a breakthrough technology national group purchasing agreement in the "non-invasive skin closure" category with Premier, Inc.
New Strong Buy Stocks for December 11th
PINC, DXPE, PFIS, CBAN and APAM have been added to the Zacks Rank #1 (Strong Buy) List on December 11, 2024.
Best Income Stocks to Buy for December 11th
PFIS, PINC and CBAN made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 11, 2024.
Best Value Stocks to Buy for December 11th
PINC, DXPE and DFH made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 11, 2024.
New Strong Buy Stocks for December 9th
PINC, MRVL, NTRS, MNDY and NBBK have been added to the Zacks Rank #1 (Strong Buy) List on December 9, 2024.
Best Value Stocks to Buy for December 9th
PINC, PRIM and DXPE made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 9, 2024.
Is First Trust Health Care AlphaDEX ETF ( FXH ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc. - Elutia ( NASDAQ:ELUT )
SILVER SPRING, Md., Dec. 02, 2024 ( GLOBE NEWSWIRE ) -- Elutia Inc. ELUT ( "Elutia" or the "Company" ) , a pioneer in drug-eluting biomatrix products, announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Management Devices with Premier, Inc.
Premier, Inc. ( PINC ) Hit a 52 Week High, Can the Run Continue?
Premier (PINC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should You Invest in the First Trust Health Care AlphaDEX ETF ( FXH ) ?
Sector ETF report for ...
Best Income Stocks to Buy for November 25th
DGICA, WTBA and PINC made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 25, 2024.
Best Value Stocks to Buy for November 25th
PINC, SCHL and DGICA made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 25, 2024.
Premier, Inc. ( PINC ) Tops Q1 Earnings and Revenue Estimates
Premier (PINC) delivered earnings and revenue surprises of 30.77% and 7.79%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
AiRISTA Awarded Asset Tracking & Management Solutions agreement with Premier, Inc.
TIMONIUM, Md., Oct. 29, 2024 /PRNewswire/ -- AiRISTA, a global leader in real time location services ( RTLS ) , has been awarded a national group purchasing agreement for Asset Tracking & Management Solutions with Premier, Inc.
SRDX Stock Down Despite FDA Clearance for Pounce XL System
Surmodics' latest regulatory achievement is likely to broaden the platform's clinical utility and significantly expand its addressable market.
EMMI Technologies Was Awarded a Remote Patient Monitoring Agreement with Premier, Inc.
ROCHESTER, N.Y., Aug. 20, 2024 /PRNewswire/ -- EMMI Technologies has been awarded a national group purchasing agreement for Remote Patient Monitoring with Premier, Inc.
Premier, Inc. ( PINC ) Tops Q4 Earnings and Revenue Estimates
Premier (PINC) delivered earnings and revenue surprises of 40.82% and 12.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Premier ( PINC ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Besides Wall Street's top -and-bottom-line estimates for Premier (PINC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
ReWalk Robotics ( LFWD ) Reports Q2 Loss, Lags Revenue Estimates
ReWalk (LFWD) delivered earnings and revenue surprises of 5.66% and 0.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The Oncology Institute, Inc. ( TOI ) Reports Q2 Loss, Misses Revenue Estimates
The Oncology Institute (TOI) delivered earnings and revenue surprises of -70% and 4.58%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Taysha Gene Therapies, Inc. ( TSHA ) Reports Q2 Loss, Lags Revenue Estimates
Taysha Gene Therapies (TSHA) delivered earnings and revenue surprises of 10% and 69.28%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
